Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Horizon Therapeutics (NQ: HZNP )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Horizon Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA® (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED)
From Horizon Therapeutics plc
Via Business Wire
Love Dividends? These 3 Stocks Are Smart Buys Right Now
With yields of 3.1%, 3.4%, and 14.3%, these stocks are hard to pass up right now. 
Via The Motley Fool
5 Diverse Medical Stocks To Buy For 2023 And Beyond
Healthcare will always be essential to society, making many health companies viable investments for growth. A look at the five top-rated stocks that investors may want to consider buying for 2023 and... 
Via Talk Markets
Horizon Therapeutics plc Named to the 2023 Fortune 100 Best Companies to Work For List
From Horizon Therapeutics plc
Via Business Wire
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today
Via Benzinga
Horizon Therapeutics' Debt Overview
Via Benzinga
3 Dow Stocks With Above-Average Dividends Yields to Buy in April
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now. 
Via The Motley Fool
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment. 
Via The Motley Fool
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
From Horizon Therapeutics plc
Via Business Wire
New Analysis of MRI Findings Show UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Asymptomatic Optic Nerve Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)
From Horizon Therapeutics plc
Via Business Wire
Here's How Much You Would Have Made Owning Horizon Therapeutics Stock In The Last 5 Years
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Amgen Sinks On Mixed Earnings As 2023 Guidance Comes Up Short
Amgen reported lighter-than-expected earnings, but sales beat forecasts. 
Via Investor's Business Daily
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources... 
Via Benzinga
Real-World Experience Shows TEPEZZA® (teprotumumab-trbw) Was Effective in Treating People With Dysthyroid Optic Neuropathy (DON)
From Horizon Therapeutics plc
Via Business Wire
7 Over-$100 Stocks That Are Worth Every Penny
To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy. 
Via InvestorPlace
Horizon Therapeutics plc - Rule 2.12 Announcement
From Horizon Therapeutics plc
Via Business Wire
Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Horizon Therapeutics plc
Via Business Wire
Horizon Therapeutics plc Opens Applications for #RAREis Global Advocate Grant Program
From Horizon Therapeutics plc
Via Business Wire
Horizon Therapeutics plc Announces Voting Results from Special Shareholder Meetings
From Horizon Therapeutics plc
Via Business Wire
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
When billionaires jump on the same trend, it’s important for investors to take notice. The pieces often don’t come together immediately, but these investors have millions of dollars in resources... 
Via Benzinga
New Data Suggest UPLIZNA® (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Did Not Increase the Risk of COVID-19 Infection or Reduce Antibody Levels From Childhood Vaccines
From Horizon Therapeutics plc
Via Business Wire
Nearly One-Third of Billionaire George Soros' Portfolio Is Invested in These 10 Stocks
One of Soros' top 10 holdings looks especially attractive right now. 
Via The Motley Fool
Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock
Two well-regarded billionaire investors -- George Soros and Paul Tudor Jones -- bought Horizon (HZNP) stock last quarter. 
Via InvestorPlace
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022
Billionaire-led investing firms scooped up shares of Paramount Global, Bank of America, and Horizon Therapeutics in Q4. 
Via The Motley Fool
Market Rally Powers Higher On Tame Fed, Meta Earnings; Apple, Google, Amazon In Focus: Weekly Review
The major indexes continued to run despite mixed-to-weak earnings. 
Via Investor's Business Daily
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline
Via Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Via Benzinga
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023
From Horizon Therapeutics plc
Via Business Wire
Rule 15 (c) Announcement – Horizon Therapeutics plc
From Horizon Therapeutics plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.